TriSalus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	137	222	313	309	263
Market Cap Growth	206.65%	-29.05%	1.52%	17.62%	-
Enterprise Value	135	212	306	278	261
PE Ratio	-	-3.77	-6.64	-10.70	-369.00
PS Ratio	6.25	12.01	25.28	36.75	-
PB Ratio	-7.35	-8.57	-1.78	-2.38	-12.22
P/FCF Ratio	-4.98	-4.35	-9.47	-12.89	-387.40
P/OCF Ratio	-5.09	-4.44	-9.70	-13.60	-387.40
EV/Sales Ratio	6.14	11.46	24.68	33.14	-
EV/EBITDA Ratio	-4.02	-3.64	-6.54	-10.46	-367.12
EV/EBIT Ratio	-3.97	-3.60	-6.49	-10.28	-367.12
EV/FCF Ratio	-4.93	-4.15	-9.24	-11.62	-385.43
Debt / Equity Ratio	-0.05	-0.06	-0.01	-	-
Debt / EBITDA Ratio	-0.03	-0.03	-0.04	-	-
Debt / FCF Ratio	-0.03	-0.03	-0.06	-	-
Quick Ratio	0.57	1.04	0.34	4.97	-
Current Ratio	0.92	1.42	0.53	5.51	-
Asset Turnover	0.94	0.77	0.06	0.04	-
Interest Coverage	-4568.36	-3688.31	-47177.00	-15.38	-
Return on Equity (ROE)	102.10%	59.00%	88.40%	82.90%	-
Return on Assets (ROA)	-272.40%	-246.20%	-24.40%	-14.60%	-
Return on Capital (ROIC)	168.18%	224.00%	21.14%	17.97%	0.50%
Earnings Yield	-46.56%	-26.55%	-15.05%	-9.34%	-0.27%
FCF Yield	-37.49%	-23.01%	-10.56%	-7.76%	-0.26%
Buyback Yield / Dilution	-44.27%	-2934.71%	-41.31%	97.37%	-
Total Shareholder Return	-44.27%	-2934.71%	-41.31%	97.37%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).